The pharmaceutical industry is at risk from Brexit
Xu, J.
(2017).
The pharmaceutical industry is at risk from Brexit.
The pharmaceutical industry is at risk from Brexit. Border delays, R&D disruption and regulatory divergence pose hazards to this important industry, writes Jianwei Xu.
| Item Type | Online resource |
|---|---|
| Copyright holders | © 2017 The Author(s) |
| Departments | LSE |
| Date Deposited | 23 Oct 2017 |
| URI | https://researchonline.lse.ac.uk/id/eprint/83815 |